ClinConnect ClinConnect Logo
Search / Trial NCT06240975

Theragun vs Dry Needling on Neck Pain, Range of Motion and Disability Among Heavy Weightlifters

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jan 28, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Theragun Dry Needling Neck Pain Range Of Motion Disability Heavy Weightlifters

ClinConnect Summary

This clinical trial is exploring two different treatments for neck pain in male weightlifters: Theragun therapy and dry needling. The goal is to see which method helps reduce neck pain, improve how well the neck moves, and lower disability among athletes who have been lifting weights for at least one to two years. The study is open to male athletes aged 20-35 who have a specific neck condition, but it excludes those with certain medical issues like migraines or recent injuries.

Participants in the trial will be randomly assigned to one of two groups. One group will receive Theragun treatment, which uses a handheld device to massage the muscles, while the other group will undergo dry needling, a technique that involves inserting thin needles into the muscles to relieve pain. If you are eligible and choose to participate, you can expect to receive one of these treatments and contribute to understanding which approach works better for neck pain relief.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • •Male athlete,
  • 20 -35 years of age,
  • Weight lifting from 1 -2 years,
  • Cervical Flexion-Rotation Test positive
  • Exclusion Criteria:
  • • Cerebrovascular diseases,
  • Migraine,
  • Cervicogenic Headache,
  • Musculoskeletal, cervical spondylosis, cervical spondylolisthesis,
  • Cervical post-operative,
  • Traumatic events in the past three months,
  • Presence of a physical or mental illness

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Amir Chand, DPT

Principal Investigator

Study Principal Investigator

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported